Get your free email accountLog in
U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British ...
Myriad Genetics, Inc. news and stories | Webmail | Email address | Mobile Clients
Copyright 2015 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Copyright © 2015 1&1 Mail & Media Inc. All rights reserved.